alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › advances

advances

3 studies tagged advances, dated 2011-11-07 to 2025-02-02. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. How to advance the pharmacological management of cognitive impairment in Parkinson's disease 2025-02-02
  2. Current Advances in Computerized Cognitive Assessment for Mild Cognitive Impairment and Dementia in Older Adults: A Systematic Review 2024-09-28
  3. Nanotechnological advances for the delivery of CNS therapeutics 2011-11-07

Studies

3 studies carry this tag.

Date range

2011 to 2025

Top journals

  • Advanced drug delivery reviews 1
  • Dementia and geriatric cognitive disorders 1
  • Journal of Parkinson's disease 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. How to advance the pharmacological management of cognitive impairment in Parkinson's disease

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Journal of Parkinson's disease 2025-02-02 Cognitive tests and assessment

    Cognitive impairment is a common non-motor symptom in people with Parkinson's disease (PD) and is associated to poor clinical outcomes.

  2. Current Advances in Computerized Cognitive Assessment for Mild Cognitive Impairment and Dementia in Older Adults: A Systematic Review

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Dementia and geriatric cognitive disorders 2024-09-28 Cognitive tests and assessment

    The review highlights the advancements in computerized cognitive assessments for assessing MCI and dementia.

  3. Nanotechnological advances for the delivery of CNS therapeutics

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Advanced drug delivery reviews 2011-11-07 Tau biomarkers

    Effective non-invasive treatment of neurological diseases is often limited by the poor access of therapeutic agents into the central nervous system (CNS).

All topic tags with their study counts